ReviewJournal of pharmaceutical health care and sciences2026
Pharmacist-driven antimicrobial stewardship: evolving roles in clinical practice.
Review in Journal of pharmaceutical health care and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) poses a major global public health threat. The effective implementation of antimicrobial stewardship (AS) is essential for optimizing antimicrobial use and improving clinical outcomes. In this context, pharmacists play a central role by managing pharmacotherapy across multiple clinical practice domains. This narrative review summarizes evidence on pharmacist-driven AS, focusing on three key areas: (i) the facilitation of proper antimicrobial use, (ii) the management of antimicrobial-related adverse events, and (iii) support for evidence-based infection control and prevention. Prospective audit and feedback, surveillance of antimicrobial consumption and outcomes, diagnostic stewardship, and educational interventions represent the core strategies through which pharmacists optimize antimicrobial use. Additionally, pharmacists can enhance treatment safety by conducting structured risk assessments and monitoring drug-specific toxicities. Pharmacists further support infection control practices through disinfectant management, outbreak response, and post-exposure prophylaxis. Finally, the integration of real-world data and structured workforce development programs is essential for sustaining and advancing pharmacist-driven AS. This review highlights the role of pharmacists as leaders in the implementation and continuous refinement of AS tailored to institutional and regional healthcare needs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.